Central Nervous System Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-08-17
Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors [Phase 1]
Phase 1 study of ramucirumab in pediatric patients with refractory solid tumors has completed with results posted.